Katona Gábor, Vereckei András
Department of Medicine and Hematology, Semmelweis University, Budapest, Hungary.
J Geriatr Cardiol. 2022 Jan 28;19(1):31-43. doi: 10.11909/j.issn.1671-5411.2022.01.006.
Cardiac resynchronization therapy (CRT) is an evidence-based effective therapy of symptomatic heart failure with reduced ejection fraction refractory to optimal medical treatment associated with intraventricular conduction disturbance, that results in electrical dyssynchrony and further deterioration of systolic ventricular function. However, the non-response rate to CRT is still 20%-40%, which can be decreased by better patient selection. The main determinant of CRT outcome is the presence or absence of significant ventricular dyssynchrony and the ability of the applied CRT technique to eliminate it. The current guidelines recommend the determination of QRS morphology and QRS duration and the measurement of left ventricular ejection fraction for patient selection for CRT. However, QRS morphology and QRS duration are not perfect indicators of electrical dyssynchrony, which is the cause of the not negligible non-response rate to CRT and the missed CRT implantation in a significant number of patients who have the appropriate substrate for CRT. Using imaging modalities, many ventricular dyssynchrony criteria were devised for the detection of mechanical dyssynchrony, but their utility in patient selection for CRT is not yet proven, therefore their use is not recommended for this purpose. Moreover, CRT can eliminate only mechanical dyssynchrony due to underlying electrical dyssynchrony, for this reason ECG has a greater role in the detection of ventricular dyssynchrony than imaging modalities. To improve assessment of electrical dyssynchrony, we devised two novel ECG dyssynchrony criteria, which can estimate interventricular and left ventricular intraventricular dyssynchrony in order to improve patient selection for CRT. Here we discuss the results achieved by the application of these new ECG dyssynchrony criteria, which proved to be useful in predicting the CRT response in patients with nonspecific intraventricular conduction disturbance pattern (the second greatest group of CRT candidates), and the significance of other new ECG dyssynchrony criteria in the potential improvement of CRT outcome.
心脏再同步治疗(CRT)是一种基于证据的有效治疗方法,用于治疗症状性心力衰竭且射血分数降低,对最佳药物治疗无效且伴有心室内传导障碍,导致电不同步和收缩期心室功能进一步恶化的患者。然而,CRT的无反应率仍为20%-40%,通过更好地选择患者可以降低这一比例。CRT疗效的主要决定因素是是否存在显著的心室不同步以及所应用的CRT技术消除它的能力。当前指南建议通过测定QRS形态和QRS时限以及测量左心室射血分数来选择适合CRT的患者。然而,QRS形态和QRS时限并非电不同步的完美指标,这导致了CRT不可忽视的无反应率,并且在大量有CRT合适基础的患者中错失了CRT植入机会。利用成像方式,设计了许多心室不同步标准来检测机械不同步,但它们在CRT患者选择中的效用尚未得到证实,因此不建议为此目的使用。此外,CRT只能消除由潜在电不同步引起的机械不同步,因此心电图在检测心室不同步方面比成像方式发挥着更大的作用。为了改善对电不同步的评估,我们设计了两个新的心电图不同步标准,它们可以估计心室间和左心室内不同步,以改善CRT患者的选择。在此我们讨论应用这些新的心电图不同步标准所取得的结果,这些结果被证明有助于预测非特异性心室内传导障碍模式患者(CRT候选者的第二大群体)的CRT反应,以及其他新的心电图不同步标准在潜在改善CRT疗效方面的意义。